Drug Discovery Featured Articles & Applications

  1. How The U.S. Can Beat China In Biotech 11/3/2025

    Lumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.

  2. When Preclinical Models Distort The Patient 11/3/2025

    Drug development's translation doesn’t fail for lack of tools. It fails when those tools remain unaligned. The industry needs a better system, one that integrates the partial truths of each platform into a predictive whole.

  3. Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads 10/31/2025

    Part one of a two-part series on FDA Commissioner Martin Makary, M.D.'s comments at the Gailen Forum in New York City on October 30, 2025.

  4. Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer 10/29/2025

    Drug Discovery Online interviews MIT’s Bob Langer on biomedical innovation, personalized medicine, longevity, and entrepreneurship—highlighting his journey, lab impact, and personal discipline.

  5. How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides 10/21/2025

    A class of enzymes previously believed to be specific and intolerant of change might actually have broad applicability.

  6. Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development 10/21/2025

    Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.

  7. The 9 Fastest-Growing Outsourcing Segments 10/21/2025

    Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.

  8. 100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing 10/17/2025

    Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.

  9. Why Drug Discovery Needs Epistemological Wrapping For Generative AI 10/14/2025

    AI in drug discovery can lead to faster decision cycles, reduced experimental burden, and more hypotheses tested per dollar spent. However, speed without rigor can be catastrophic.

  10. Discovery On Hold: How Shutdowns Stall Science And Shake Trust 10/10/2025

    When the federal government shuts down and appropriations lapse, the ripple effects reach deep into early drug development efforts. FDA slows regulatory intake, NIH freezes grant reviews and awards, clinical trials are disrupted, and talent pipelines tighten as student and work visas remain in limbo.